DexCom, Inc. (DXCM)

NasdaqGS Currently down 0.95 (-1.33%) in today's trading session

5 members of Congress have disclosed 19 trades in DexCom, Inc. (DXCM) via STOCK Act filings. The most recent disclosure was a sale by Jefferson Shreve on 12 May 2025. The most active traders have been Josh Gottheimer (11), Jefferson Shreve (3), and Kevin Hern (2). Aggregate disclosed activity totals roughly $255.5K in purchases and $204K in sales (midpoint estimates from bracketed disclosure amounts).

DexCom, Inc. is currently trading at $70.48, positioned at 46% of its 52-week range ($54.11 – $89.98).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$70.48
24h Change
-0.95 (-1.33%)
52 Week Range
$54.11$89.98
View on NASDAQ

DexCom, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for DXCM

Select to highlight on chart
12 transactions
Compliance: 63%
Jefferson Shreve12 May 202522 Jun 2025SaleStock$15,001 - $50,000N/A
Jefferson Shreve8 May 202522 Jun 2025PurchaseStock$15,001 - $50,000N/A
Jefferson Shreve7 Apr 20258 May 2025SaleStock$15,001 - $50,000N/A
Kevin Hern31 Dec 202415 Jan 2025SaleStock$50,001 - $100,000N/A
Kevin Hern1 Jul 202115 Sept 2021PurchaseStock$100,001 - $250,000N/A
Gilbert Cisneros22 Dec 202011 Jan 2021SaleStock$1,001 - $15,000N/A
Susie Lee2 Oct 20208 Dec 2020SaleStock$1,001 - $15,000N/A
Gilbert Cisneros16 Sept 202014 Oct 2020PurchaseStock$1,001 - $15,000N/A
Josh Gottheimer13 Aug 202020 Sept 2020SaleStock$1,001 - $15,000N/A
Josh Gottheimer11 May 202010 Jun 2020SaleStock$1,001 - $15,000N/A
Josh Gottheimer16 Jul 201916 Sept 2019SaleStock$1,001 - $15,000N/A
Josh Gottheimer13 Jun 201918 Jul 2019SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$27.2B

Volume

3.24M

Beta

1.45

P/E Ratio

30.25

Fundamentals

EPS

$2.33

Div. Yield

Open

$71.08

Day Range

$70.28 — $71.43

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
Jacob Steven Leach
IPO Date
2005-04-14

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individua...

Earnings

Next Report

Q2 2026

30 Jul

EPS Est.

$0.61

Rev. Est.

$1.3B

Days Until

7

Recent Quarters

Q1 202630 Apr
EPS$0.56
Beat 20.3%
Q4 202512 Feb
EPS$0.68
Beat 4.6%
Q3 202530 Oct
EPS$0.61
Beat 5.9%
Q2 202530 Jul
EPS$0.48
Beat 8.2%
Q1 20251 May
EPS$0.32
Miss 2.2%
Q4 202413 Feb
EPS$0.45
Miss 6.1%
Q3 202424 Oct
EPS$0.45
Beat 2.3%
Q2 202425 Jul
EPS$0.43
Beat 10.3%
Q1 202425 Apr
EPS$0.32
Beat 18.5%
Q4 20238 Feb
EPS$0.50
Beat 16.3%
Q3 202326 Oct
EPS$0.50
Beat 47.1%
Q2 202327 Jul
EPS$0.34
Beat 47.8%
Q1 202327 Apr
EPS$0.17
Beat 13.3%
Q4 20229 Feb
EPS$0.34
Beat 30.8%
Q3 202227 Oct
EPS$0.28
Beat 16.7%
Q2 202228 Jul
EPS$0.17
Beat 0.0%
Q1 202228 Apr
EPS$0.08
Miss 38.5%
Q4 202110 Feb
EPS$0.17
Miss 22.7%
Q3 202128 Oct
EPS$0.22
Beat 37.5%
Q2 202129 Jul
EPS$0.19
Beat 72.7%
Q1 202129 Apr
EPS$0.08
Beat 0.0%
Q4 202011 Feb
EPS$0.23
Beat 0.0%
Q3 202027 Oct
EPS$0.24
Beat 50.0%
Q2 202028 Jul
EPS$0.20
Beat 150.0%
Q1 202028 Apr
EPS$0.11
Beat 206.7%
Q4 201913 Feb
EPS$0.29
Beat 61.1%
Q3 20196 Nov
EPS$0.16
Beat 220.0%
Q2 201931 Jul
EPS$0.02
Beat 527.0%
Q1 20191 May
EPS$-0.01
Miss 68.1%
Q4 201821 Feb
EPS$0.14
Beat 220.8%
Q3 20186 Nov
EPS$0.04
Beat 270.0%
Q2 20181 Aug
EPS$-0.03
Beat 40.0%
Q1 20182 May
EPS$-0.08
Beat 0.0%
Q4 201727 Feb
EPS$0.03
Beat 286.6%
Q3 20171 Nov
EPS$-0.01
Miss 74.8%
Q2 20171 Aug
EPS$-0.04
Beat 33.3%
Q1 20172 May
EPS$-0.12
Beat 14.3%
Q4 201628 Feb
EPS$-0.02
Miss 6.9%
Q3 20161 Nov
EPS$-0.06
Miss 69.3%
Q2 20162 Aug
EPS$-0.06
Miss 106.0%
Q1 201627 Apr
EPS$-0.06
Beat 0.0%
Q4 201523 Feb
EPS$0.01
Beat 257.1%
Q3 20154 Nov
EPS$-0.02
Q2 20155 Aug
EPS$-0.01
Miss 77.9%
Q1 201529 Apr
EPS$-0.04
Miss 60.8%
Q4 201425 Feb
EPS$0.01
Beat 169.5%
Q3 20146 Nov
EPS$-0.02
Miss 20.7%
Q2 20146 Aug
EPS$-0.03
Miss 13.7%
Q1 20141 May
EPS$-0.04
Miss 108.8%
Q4 201320 Feb
EPS$-0.01
Miss 44.5%
Q3 20136 Nov
EPS$-0.02
Miss 38.5%
Q2 20137 Aug
EPS$-0.04
Miss 9.9%
Q1 20131 May
EPS$-0.04
Miss 6.8%
Q4 201221 Feb
EPS$-0.04
Miss 25.4%
Q3 20121 Nov
EPS$-0.06
Beat 0.0%
Q2 20126 Aug
EPS$-0.05
Beat 0.0%
Q1 20122 May
EPS$-0.05
Beat 0.0%
Q4 201123 Feb
EPS$-0.04
Miss 6.3%
Q3 20112 Nov
EPS$-0.05
Miss 27.4%
Q2 20113 Aug
EPS$-0.03
Miss 6.8%
Q1 20113 May
EPS$-0.05
Beat 0.0%
Q4 20103 Mar
EPS$-0.04
Beat 20.0%
Q3 20104 Nov
EPS$-0.06
Miss 28.4%
Q2 20103 Aug
EPS$-0.05
Beat 0.0%
Q1 20105 May
EPS$-0.07
Miss 16.7%
Q4 20099 Mar
EPS$-0.06
Beat 14.3%
Q3 20094 Nov
EPS$-0.07
Beat 12.5%
Q2 20093 Aug
EPS$-0.08
Beat 0.0%
Q1 20096 May
EPS$-0.08
Beat 0.0%
Q4 20085 Mar
EPS$-0.11
Beat 0.0%
Q3 200810 Nov
EPS$-0.12
Beat 0.0%
Q2 20085 Aug
EPS$-0.12
Miss 9.1%
Q1 20088 May
EPS$-0.11
Miss 10.0%
Q4 200711 Mar
EPS$-0.11
Miss 10.0%
Q3 200730 Oct
EPS$-0.10
Beat 0.0%
Q2 200730 Jul
EPS$-0.10
Beat 0.0%
Q1 20079 May
EPS$-0.10
Beat 0.0%
Q4 200627 Feb
EPS$-0.10
Beat 16.7%
Q3 200623 Oct
EPS$-0.12
Miss 20.0%
Q2 200620 Jul
EPS$-0.10
Beat 9.1%
Q1 200615 May
EPS$-0.11
Beat 8.3%
Q4 200527 Feb
EPS$-0.12
Miss 71.4%
Q3 20051 Nov
EPS$-0.06
Beat 14.3%
Q2 20052 Aug
EPS$-0.07
Miss 16.7%
Q2 20052 Aug
EPS$-0.07

5 politicians traded within 30 days

No dividend data available for this stock.

Stock Splits

Split History

13 Jun 2022Stock Split
Ratio4:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

JNJ

Johnson & Johnson

63
$259.27+3.64 (+1.42%)
Healthcare
2 politicians both hold this
Same sector: Healthcare
+1 more reason
2 politicians
View Stock

MSFT

Microsoft Corporation

56
$381.58-8.76 (-2.24%)
Technology
2 politicians both hold this
$24M in total holdings
2 politicians
View Stock

LIN

Linde plc

49
$506.32-2.35 (-0.46%)
Basic Materials
3 politicians hold this stock
Significant holdings value
3 politicians
View Stock

Frequently Asked Questions about DXCM

Which members of Congress have traded DXCM?
5 members of Congress have disclosed 19 trades in DexCom, Inc. (DXCM) under the STOCK Act. The most active traders are Josh Gottheimer, Jefferson Shreve, and Kevin Hern.
When was DXCM most recently disclosed by Congress?
The most recent DXCM disclosure was a sale by Jefferson Shreve on 12 May 2025.
What is the total disclosed congressional trading volume for DXCM?
Members of Congress have disclosed approximately $255.5K in DXCM purchases and $204K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in DXCM?
This DXCM page updates as soon as new STOCK Act disclosures are filed for DexCom, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.